Nesterov A, Wiley H S, Gill G N
Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093, USA.
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8719-23. doi: 10.1073/pnas.92.19.8719.
Ligand-activated epidermal growth factor receptors (EGFRs) associate with coated pit adaptor proteins (AP2) in vivo, implying a mechanism for receptor retention in coated pits during internalization. Using an in vitro binding assay, we localized the adaptor binding determinant to residues 970-991 of EGFRs and confirmed specificity by competition with a synthetic peptide corresponding to this sequence. A mutant EGFR lacking this AP2 binding determinant did not associate with AP2 in vivo but demonstrated internalization and down-regulation kinetics indistinguishable from its wild-type counterpart. Immunocytochemistry confirmed ligand-induced internalization of the mutant EGFR. These data suggest that endocytic determinants are distinct from AP2 binding determinants and that processes other than association with AP2 regulate endocytosis of EGFRs.
配体激活的表皮生长因子受体(EGFRs)在体内与被膜小窝衔接蛋白(AP2)相关联,这意味着在内在化过程中受体保留在被膜小窝中的一种机制。通过体外结合试验,我们将衔接蛋白结合决定簇定位到EGFRs的970 - 991位残基,并通过与对应于该序列的合成肽竞争来确认特异性。缺乏这种AP2结合决定簇的突变型EGFR在体内不与AP2相关联,但表现出与野生型对应物难以区分的内在化和下调动力学。免疫细胞化学证实了突变型EGFR的配体诱导的内在化。这些数据表明,内吞决定簇与AP2结合决定簇不同,并且除了与AP2相关联之外的其他过程调节EGFRs的内吞作用。